10-Q: Nordson Corp Reports Strong Q3 2026 Earnings Growth

Nordson Corporation announced a significant increase in net income and diluted EPS for the third quarter of fiscal year 2026, driven by robust sales growth across its segments and improved operating profit.

Summary

• Nordson Corporation reported strong financial results for the third quarter and first nine months of fiscal year 2026.
• Sales increased by 10.3% to $817.7 million for the third quarter and 9.2% to $2.23 billion for the nine-month period.
• Net income rose by 21.5% to $152.8 million ($2.73 diluted EPS) for the third quarter and 21.2% to $403.5 million ($7.20 diluted EPS) for the nine-month period.
• Operating profit saw a substantial increase of 18.8% for the quarter and 17.9% for the nine months.
• The company's gross margin improved to 55.5% in Q3 2026 from 54.8% in Q3 2025.
• Cash flow from operations was strong, totaling $570.5 million for the nine months ended July 31, 2026.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive report, with strong revenue growth, improved profitability, and solid cash flow generation, indicating robust operational performance and financial health.

Positives

• Significant year-over-year increase in net sales for both the third quarter (10.3%) and the first nine months (9.2%).
• Substantial growth in net income (21.5% for Q3, 21.2% for nine months) and diluted EPS (23.0% for Q3, 23.5% for nine months).
• Improved gross margin percentage to 55.5% in Q3 2026 from 54.8% in Q3 2025.
• Strong operating profit growth of 18.8% for the quarter and 17.9% for the nine months.
• Robust cash flow from operating activities, increasing by $54.2 million to $570.5 million for the nine-month period.
• Advanced Technology Solutions (ATS) segment showed exceptional organic sales growth of 30.9% in Q3 and 20.1% year-to-date.
• Effective management of interest expense, which decreased due to lower average debt levels.
• Strong liquidity position with $113.4 million in cash and cash equivalents and $1.14 billion in available borrowing capacity.

Negatives

• A pension settlement charge of $24.0 million was incurred in the nine-month period, impacting net income.
• Other expense - net increased significantly in Q3 2026 due to unrealized losses on minority investments ($14.9 million).
• Divestiture and related charges of $12.2 million were recorded in the current period.
• Segment EBITDA for Industrial Precision Solutions (IPS) decreased by 170 basis points in Q3 and 190 basis points year-to-date, despite higher sales, due to investments and inflationary pressures.
• The Medical and Fluid Solutions (MFS) segment experienced headwinds from near-term product start-ups.

Risks

• The impact of international conflicts, changes in trade policies, tariffs, and other import/export regulations could negatively impact cash flow and liquidity.
• Forward-looking statements are subject to risks and uncertainties including U.S. and international economic and political conditions, currency exchange rates, acquisition integration challenges, and changes in tax law.
• The company is contractually restricted from selling shares in a minority interest investment until December 2028.

Future Outlook

The company believes it is well-positioned to manage liquidity needs and expects cash from operations, combined with available borrowing capacity, to be more than adequate for the next twelve months and beyond. However, international conflicts and trade policy changes could negatively impact future cash flow and liquidity.

Management Comments

• Nordson is an innovative precision technology company that leverages a scalable growth framework expected to deliver top tier growth with leading margins and returns.
• Our strategy for long-term growth is based on solving customers needs globally.
• The Company believes it has the ability to generate and obtain adequate amounts of cash to meet its short-term and long-term needs for cash.

Industry Context

StockSavvy.ai notes that Nordson's performance, particularly the strong growth in the Advanced Technology Solutions segment, aligns with broader industry trends favoring specialized technology solutions in electronics and medical devices. The company's diversified end markets provide resilience.

Comparison to Industry Standards

• Nordson's Q3 2026 gross margin of 55.5% appears strong compared to many industrial manufacturing peers, though specific industry benchmarks vary widely.
• The company's double-digit sales growth in key segments like ATS (30.9% organic in Q3) outpaces many diversified industrial conglomerates.
• The reported diluted EPS growth of 23.0% in Q3 2026 is a robust performance indicator, often exceeding industry averages for mature industrial companies.

Legal Proceedings

• The company is involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee, and other matters arising from the normal course of business. Management does not believe losses in excess of accrued amounts would be material.

Stakeholder Impact

• Shareholders: Positive impact from increased net income, EPS, and potential for continued share repurchases and dividends.
• Employees: Continued investment in innovation may lead to new opportunities; however, inflationary pressures could impact compensation.
• Creditors: Strong cash flow and liquidity position suggest continued ability to meet debt obligations.

Next Steps

• Continue to focus on solving customer needs globally.
• Manage liquidity needs through cash on hand, operations, and available borrowings.
• Monitor and adapt to impacts of international conflicts, trade policies, and regulations.

Key Dates

Recommendation

While the results are strong and indicate positive operational performance, the increased 'other expense' due to minority investment losses and the pension settlement charge, coupled with ongoing geopolitical and trade policy risks, warrant a cautious 'hold' stance. The company's solid execution and growth prospects are balanced by external uncertainties.

Keywords

Nordson Corporation, Quarterly Report, Form 10-Q, Industrial Precision Solutions, Medical and Fluid Solutions, Advanced Technology Solutions, Earnings Per Share, Revenue Growth